Meghan Fitzgerald
Director · Roivant Sciences Ltd.
IndividualSelling only8 10b5-1 trades
- 2025
- Sep 18, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Meghan Fitzgerald files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
- Daniel Allen Gold - $147.38M in ROIV purchases and sales in the last 12 months
- QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
- Mayukh Sukhatme - $109.13M in ROIV purchases and sales in the last 12 months
- Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
- Eric Venker - $80.09M in ROIV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Meghan Fitzgerald?
Meghan Fitzgerald is a corporate insider, tracked as Director of Roivant Sciences Ltd. (ROIV). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Meghan Fitzgerald submitted recently?
4 primary Form 4 filings in the last 90 days, covering 1 company.
Has Meghan Fitzgerald been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($3.27M) across all tracked filings.
